News and Updates

Managing childhood migraine


Background Childhood migraines create a significant health burden and are probably under-diagnosed and treated. Objective/s The aim of this article… read more >

3 types of diabetes medication recalled over ‘impurity’


SINGAPORE: Three types of metformin diabetes medications are being recalled after they were found to contain trace amounts of an… read more >

Dapagliflozin slows eGFR decline in diabetics


Dapagliflozin is able to delay renal disease progression among patients with type 2 diabetes, even in those with normal kidney… read more >

Sulfites in wine may trigger headache in young adults


Sulfite concentration in wine seems to contribute to the occurrence of headaches in individuals who are predisposed to wine-induced headaches,… read more >

Computer Use Found To Reduce Cognitive Decline Risk


An observational study suggests people in their 70s that use a computer, play games, and participate in social activities might… read more >

NUS scientists develop blood test for Alzheimer’s


A new blood test for diagnosing Alzheimer’s disease could be available within the next five years.   Researchers from the… read more >

What Is Parkinson’s?


Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominately dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called substantia nigra…. read more >

These Headache Stretches Work as Well as Pain Pills


Many headaches are caused by muscles in the neck area. If you work at a desk every day and don’t have… read more >

World’s first migraine-specific prevention treatment available in Singapore


Aimovig is the world’s first migraine-specific prevention treatment developed specifically to block the receptor which plays a critical role in… read more >

What we know — and don’t know — about a new migraine drug


Aimovig was recently approved for use by the U.S. Food and Drug Administration   Migraines have plagued humans since time… read more >